Stimulant Doping Agents Used in Brazil: Prevalence, Detectability, Analytical Implications, and Challenges

REFERENCES

• Aguilera, R., Chapman, T. E., Pereira, H., Oliveira, G. C., Illanes, R. P., Fernandes, T. F., … Neto, F.A. (2009). Drug testing data from the 2007 Pan American Games: delta13C values of urinary androsterone, etiocholanolone and androstanediols determined by GC/C/IRMS. The Journal of Steroid Biochemistry and Molecular Biology, 115, 107–114.
   PubMed Web of Science ®Google Scholar
• Alaranta, A., Alaranta, H., Holmila, J., Palmu, P., Pietilä, K., & Helenius, I. (2006). Self-reported attitudes of elite athletes towards doping: differences between type of sport. International Journal of Sports Medicine, 27(10), 842–846.
   PubMed Web of Science ®Google Scholar
• Algars, M., Santtila, P., & Sandnabba N. K. (2010). Conflict gender identity, body dissatisfaction, and disordered eating in adult men and women. Sex Roles, 63, 118–125.
   Web of Science ®Google Scholar
• Ammann, J., McLaren, J. M., Gerostamoulos, D., & Beber, J. (2012). Detection and quantification of new designer drugs in human blood: Part 1—synthetic Cannabinoids. Journal of Analytical Toxicology, 36, 372–380.
   PubMed Web of Science ®Google Scholar
• Andrade, A.G., Duarte, P. & Oliveira, L. G. (2010) I Levantamento Nacional Sobre O Uso De Álcool, Tabaco E Outras Drogas Entre Universitarios das 27 Capitais Brasileiras, Secretaria Nacional Politicas sobre Drogas, Brasilia. Brasilia: Secretaria Nacional de Políticas sobre Drogras.
   Google Scholar
• ANVISA, Agência Nacional de Vigilância Sanitária, (2006) Pós-Comercialização Pós-Uso/Regulação de Mercado/Publicações Regulação Economica. Comunicado n° 11, de 23 de junho de 2006 0 Publicado no D.O.U. de 27 de junho de 2006. Brasil: Diário Oficial da União (DOU).
   Google Scholar
• Aquino Neto, F. R. (2001). The athlete's role in society and doping control in sports. Revista Brasileira de Medicina do Esporte, 7, 138–148.
   Google Scholar
• Araújo, L. R., Andreolo, J., & Silva, M. S. (2002). Utilização de suplemento alimentar e anabolizante por praticantes de musculação nas academias de Goiânia-Go. Revista Brasileira Ciência e Movimento, 10, 13–18.
   Google Scholar
• Arias, E. D. (2006). Trouble en Route: Drug trafficking and Clientelism in Rio de Janeiro shantytowns. Qualitative Sociology, 29, 427–445.
   Google Scholar
• Arrais, P. S. D., Coelho H. L. L, Batista M. C. D. S., Carvalho M. L., Righi R. E., & Arnau, J. M. (1997). Aspects of self-medication in Brazil. Journal of Public Health, 31, 71–77.
   Google Scholar
• Avois, L., Robinson, N., Saudan, C., Baume, N., Mangin, P., & Saugy, M. (2006). Central nervous system stimulants and sport practice. British Journal of Sports Medicine, 40 (Suppl 1), i16–i20.
   PubMed Web of Science ®Google Scholar
• Barroso, O, Handelsman, D. J., Strasburger, C., & Thevis, M. (2012). Analytical challenges in the detection of peptide hormones for anti-doping purposes. Bioanalysis, 4, 1577–1590.
   PubMed Web of Science ®Google Scholar
• Baumann, G. P. (2012) Growth hormone doping in sports: A critical review of use and detection strategies. Endocrine Reviews, 33, 155–186.
   PubMed Web of Science ®Google Scholar
• Bento, R. M. A., Damasceno, L. M. P., Pereira, H. M. G., Gomes, L. N. L. F., Cardoso, J. N., & Aquino Neto, F. R. (2001). Evaluation of some energetic and nutritional supplements in Brazil: Can they originate a positive case for stimulants in doping control?. In: W. Shänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (Eds.), Recent advances in doping analysis. (pp. 293–297). Cologne: Sport und Buch Strauβ.
   Google Scholar
• Birkenfeld, A. L., Schroeder, C., Boschmann M., & Tank J. (2002). Paradoxical effect of sibutramine on autonomic cardiovascular regulation. Circulation, 106, 2459–2465.
   PubMed Web of Science ®Google Scholar
• Bogen, I. L., Haug, K. H., Myhre, O., & Fonnum, F. (2003). Short- and long-term effects of MDMA (“ecstasy”) on synaptosomal and vesicular uptake of neurotransmitters in vitro and ex vivo. Neurochemistry International, 43(4–5), 393–400. B
   Web of Science ®Google Scholar
• Boghosian, T., Mazzoni, I., Barroso, O., & Rabin, O. (2011) Investigating the use of stimulants in out-of-competition sport samples. Journal of Analytical Toxicology, 35, 613–616.
   PubMed Web of Science ®Google Scholar
• Boyadjiev, N., Georgieva, K., Massaldjieva, R., & Gueorguiev, S. (2000). Reversible hypogonadism and azoospermia as a result of anabolic-androgenic steroid use in a bodybuilder with personality disorder. A case report. Journal Sports Medicine Physical Fitness, 40(3), 271–274.
   PubMed Web of Science ®Google Scholar
• Brailsford, A. D., Gavrilovic, I., Ansell, R.J., Cowan, D. A, & Kicman, A. T. (2012) Two-dimensional gas chromatography with heart-cutting for isotope ratio mass spectrometry analysis of steroids in doping control. Drug Testing and Analysis, 4(12), 962–969
   PubMed Web of Science ®Google Scholar
• Bulcão, R., Solange Cristina Garcia, S. C., Limberger, R. P., Baierle, M., Chasin, A. A. M. C., Thiesen, F. V., & Tavares, R. (2012). Designer drugs: aspectos analíticos e biológicos. Química Nova, 35, 149–158.
   Google Scholar
• Caballero, M. (2013). Atacante do Fluminense, Michael é suspenso por 16 meses por doping. Jornal O Globo. Publicado em 05/09/2013 –16h02 em: http://oglobo.globo.com/campeonato-brasileiro-2013/atacante-do-fluminense-michael-suspenso-por-16-meses-por-doping-9841133
   Google Scholar
• Campos, J. M., Oliveira, J. S., Costa, D. M., Machado, C. D., Alvarenga, J. R., Torres, L. O., … Cançado, R. L. (1985). Prescrição de medicamentos por balconistas de 72 farmácias de Belo Horizonte/MG em maio de 1983. Jornal de Pediatria, 59, 307–312.
   Google Scholar
• Cavalcanti, G. A., Garrido, B. C., Leal, F. D., Padilha, M. C., de la Torre, X., Pereira, H. M., & Aquino Neto, F. R. (2010). Analysis of exemestane and 17β-hydroxyexemestane in human urine by gas chromatography/mass spectrometry: Development and validation of a method using MO-TMS derivatives. Rapid Communications Mass Spectrometry, 24, 3297–3302.
   PubMedGoogle Scholar
• Cavalcanti, G. A., Leal, F. D., Garrido, B. C., Padilha M. C., & Aquino Neto, F. R. (2012). Detection of designer steroid methylstenbolone in “nutritional supplement” using gas chromatography and tandem mass spectrometry: Elucidation of its urinary metabolites. Steroids, 78(2), 228–233.
   PubMed Web of Science ®Google Scholar
• Cole, E. R., Arpini, A. F., Andrade, C. R., & Biancard, E. F. (2009). Terapia farmacológica da obesidade: uma análise crítica e reflexiva das prescrições de catecolaminérgicos por uma farmácia de manipulação do município de Vila Velha, Espírito Santo. Revista Eletronica de Farmácia, 6, 42–61.
   Google Scholar
• Delbeke, F. T., Debackere, M., Jonckheere, J. A., & De Leenheer, A. P. (1983). Pentafluorobenzoyl derivatives of doping agents. I. Extractive benzoylation and gas chromatography with electron-capture detection of primary and secondary amines. Journal of Chromatography, 273, 141–149.
   PubMed Web of Science ®Google Scholar
• Deventer, K., Roels, K., Delbeke, F. T., & Van Eenoo, P. (2011). Prevalence of legal and illegal stimulanting agents in sports. Analytical and Bioanalytical Chemistry, 401, 421–432.
   PubMed Web of Science ®Google Scholar
• Deventer, K., Van Eenoo, P., Baele, G., Pozo, O. J., Van Thuyne, W., & Delbeke, F. T. (2009). Interpretation of urinary concentrations of pseudoephedrine and its metabolite cathine in relation to doping control. Drug Testing and Analysis, 1(5), 209–213.
   PubMed Web of Science ®Google Scholar
• Donike, M. (1973). Acylation with bis(acylamides). N-methyl-bis(trifluoroacetamide) and bis(trifluoroacetamide), two new reagents for trifluoroacetylation. Journal of Chromatography, 78, 273–279.
   PubMed Web of Science ®Google Scholar
• Donike, M., Jaenicke, L., Stratmann, D., & Hollmann, W. (1970). Gas chromatographic detection of nitrogen-containing drugs in aqueous solutions by means of the nitrogen detector. Journal of Chromatography, 52, 237–250.
   PubMed Web of Science ®Google Scholar
• Duailibi, L. B., Ribeiro, M., & Laranjeira, R. (2008). Profile of cocaine and crak users in Brazil. Cadernos de Saúde Pública, 24, s545–s557.
   PubMedGoogle Scholar
• Eicher, R. E. (1993) Ergolytic drugs in medicine and sports. American Journal of Medicine, 94, 205–211.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. (2010). European Medicines Agency recommends suspension of marketing authorization for sibutramine. Press release of the European Medicines Agency. Retrieved December 23, 2012, from European Medicines Agency. Web site: (http://www.ema.europa.eu/pdfs/human/referral/sibutramine/3940810en.pdf.
   Google Scholar
• Ferri, C. P., & Gossop, M. (1999). Route of cocaine administration: Patterns of use and problems among a brazilian sample. Addictive Behaviors, 24, 815–821.
   PubMed Web of Science ®Google Scholar
• Fitzgerald, J. L., & Reid, J. J. (1990). Effects of methylenedioxymethamphetamine on the release of monoamines from rat brain slices. European Journal of Pharmacology, 191(2), 217–220.
   PubMed Web of Science ®Google Scholar
• Flenker, U. (2012). Isotope ratio mass spectrometry –history and terminology in brief. Drug Testing and Analysis, 4, 893–896.
   PubMed Web of Science ®Google Scholar
• Fragkaki, A. G., Tsantili-Kakoulidou, A., Angelis, Y. S., Koupparis, M., & Georgakopoulos, C. (2009). Gas chromatographic quantitative structure-retention relationships of trimethylsilylated anabolic androgenic steroids by multiple linear regression and partial least squares. Journal of Chromatography A, 1216, 8404–8420.
   PubMed Web of Science ®Google Scholar
• Girón, A. J., Deventer, K., Roels, K., & Van Eenoo, P. (2012). Development and validation of an open screening method for diuretics, stimulants and selected compounds in human urine by UHPLC-HRMS for doping control. Analytica Chimica Acta, 721, 137–46.
   PubMed Web of Science ®Google Scholar
• Guindalini, C., Vallada, H., Breen, B., & Laranjeira, R. (2006). Concurrent crack and powder cocaine users from São Paulo: Do they represent a different group?. BMC Public Health, 6, 1–7.
   PubMed Web of Science ®Google Scholar
• Hallberg, M. (2011) Impact of anabolic androgenic steroids on neuropeptide systems. Mini-Reviews in Medicinal Chemistry, 11, 399–408.
   PubMed Web of Science ®Google Scholar
• Hatsukami, D. K., & Fischman, M. W. (1996). Crack cocaine and cocaine hydrochloride. Are the differences myth or reality? JAMA: the journal of the American Medical Association, 276(19), 1580–1588.
   PubMed Web of Science ®Google Scholar
• Heineck, I., Schenkel, E. P., & Vidal, X. (1998). Medicamentos de venta libre en el Brasil. Revista panamericana de salud pública, 3, 385–391.
   PubMedGoogle Scholar
• Hemmersbach, P. (2008). History of mass spectrometry at the Olympic Games. Journal of Mass Spectrometry, 43, 839–853.
   PubMed Web of Science ®Google Scholar
• Hemmersbach, P., & de la Torre, R. (1996). Stimulants, narcotics and beta-blockers: 25 years of development in analytical techniques for doping control. Journal of Chromatography B Biomedical Applications, 687, 221–238.
   PubMed Web of Science ®Google Scholar
• Holt, R. I., Erotokritou-Mulligan, I., & Sönksen, P. H. (2009). The history of doping and growth hormone abuse in sport. Growth Hormone & IGF Research, 19(4), 320–326.
   PubMed Web of Science ®Google Scholar
• INMETRO. (2012). ABNT NBR ISO/IEC 17025:2005, General requirements for the competence of testing and calibration laboratories, ABNT. Retrieved December 23, 2012 from INMETRO. Web site: http://www.inmetro.gov.br/credenciamento/ acre_lab.asp.
   Google Scholar
• INPAD, Instituto Nacional de Ciências e Tecnologia para Políticas Públicas do Álcool e Outras Drogas. (2013) O uso de cocaine e crack no Brasil. Retrieved September 10, 2013 from INPAD. Web site: http://inpad.org.br/wp-content/uploads/2013/ 03/LENAD_PressRelease _Coca.pdf
   Google Scholar
• Jeukendrup, A. E., Randell R. (2011). Fat burners: Nutrition supplements that increase fat metabolism. Obesity reviews, 12, 841–51.
   PubMed Web of Science ®Google Scholar
• Jones A.R., & Pichot J. T. (2010). Stimulant use in sports. The Amercian Journal on Addictions, 7, 243–255.
   Google Scholar
• Kanayama, G., Hudson, J. I., & Pope Jr., H. G. (2010). Illicit anabolic-androgenic steroid use. Hormones and Behavior, 58(1), 111–121.
   PubMed Web of Science ®Google Scholar
• Kanayama, G., Pope Jr., & Hudson, J. I. (2001). “Body Image” drugs: A growing psychosomatic problem. Psychother Psychosom, 70, 61–65.
   PubMed Web of Science ®Google Scholar
• Karch, S.B. (1998). Celebrity drug endorsements. In: S. B. Karch (Ed.), A brief history of cocaine. (pp. 1–18). Boca Raton: CRC Press.
   Google Scholar
• Kim, J., Kang, S. K., Jung, H. S., Chun, Y. S., Trilk, J., & Jung, S. H. (2011). Dietary supplementation patterns of Korean Olympic athletes participating in the Beijing 2008 Summer Olympic Games. Internacional Journal of Sport Nutrition and Exercise Metabolism, 21, 166–174.
   PubMed Web of Science ®Google Scholar
• Kohler, M., Thomas, A., Geyer, H., Petrou, M., Schänzer, W., & Thevis, M. (2010). Confiscated black market products and nutritional supplements with non-approved ingredients analyzed in the cologne doping control laboratory 2009. Drug Testing and Analysis, 2, 533–537.
   PubMed Web of Science ®Google Scholar
• Laboissière, P. (2012). Anvisa deve publicar nova análise sobre sibutramina: Agencia Brasil. Retrieved April 09, 2014, from http://exame.abril.com.br/brasil/noticias/anvisa-deve-publicar- nova-analise-sobre-sibutramina.
   Google Scholar
• Lippi G., Franchini M., Banfi G (2011). Biochemistry and physiology of anabolic androgenic steroids doping. Mini-Reviews in Medicinal Chemistry, 11, 362–373.
   PubMed Web of Science ®Google Scholar
• Lopez-Avila V., & Zorio M. (2013). Identification of methylhexaneamine by GC high-resolution TOFMS and soft ionization. Forensic Science International, 231, 113–119.
   PubMed Web of Science ®Google Scholar
• Maldaner, A. O., Schmidt, L. L., Locatelli, M. A. F., Jardim, W. F., Sodré, F. F., Almeida, F. V., … Silva, C. M. (2012). Estimating cocaine consumption in the Brazilian Federal District (FD) by sewage analysis. Journal of Brazilian Chemical Society, 23, 861–867.
   Web of Science ®Google Scholar
• Martin, R. T. (1970). The role of Coca in the history, religion, and medicine of South American Indians. Economic Botany, 24, 422–438.
   Web of Science ®Google Scholar
• Maughan, R. J., Greenhaffb P. L., & Hespel, P. (2011). Dietary supplements for athletes: Emerging trends and recurring themes. Journal of Sports Sciences, 29, S57–S66.
   PubMed Web of Science ®Google Scholar
• Maughan, R. J., King, D.S., & Lea, T. (2004) Dietary supplements. Journal Sports Science, 22, 95–113.
   PubMed Web of Science ®Google Scholar
• Maughan, R. J., & Shirreffs, S. M. (2012). Nutrition for sports performance: Issues and opportunities. Proceedings of the Nutrition Society, 71, 112–119.
   PubMed Web of Science ®Google Scholar
• Meyer, M. R., & Maurer, H. H. (2012). Current status of hyphenated mass spectrometry in studies of the metabolism of drugs of abuse, including doping agents. Analytical and Bionalytical Chemistry, 402, 195–208.
   PubMed Web of Science ®Google Scholar
• Nappo, S. A., Tabach, R., Noto, A. R., Galduróz, J. C. F., & Carlini, E. A. (2002). Use of anorectic amphetamine-like drugs by Brazilian women, Eating Behaviors, 3(2), 153–165.
   PubMedGoogle Scholar
• Nisoli, E., & Carruba, M. O. (2000). An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action. Obesity Reviews, 1, 127–139.
   PubMedGoogle Scholar
• Parkinson, A. B., & Evans, N. A. (2006). Anabolic androgenic steroids: A survey of 500 users. Medicine and Science in Sports and Exercise, 38(4), 644–651.
   PubMed Web of Science ®Google Scholar
• Parr, M. K., Opfermann, G., Geyer, H., Westphal, F., Sönnichsen, F. D., Zapp, J., … Schänzer, W. (2011) Seized designer supplement named “1-Androsterone”: Identification as 3β-hydroxy-5α-androst-1-en-17-one and its urinary elimination. Steroids, 76, 540–547.
   PubMed Web of Science ®Google Scholar
• Parr M. K., Ulrich Flenker, U., & Schänzer, W. (2010). Sports-related issues and biochemistry of natural and synthetic anabolic substances. Endocrinology and Metabolism Clinics of North America, 39, 45–57.
   PubMed Web of Science ®Google Scholar
• Pereira, H. M. G., Marques, M. A. S., Cardoso J. N., & Aquino Neto, F. R. (2002). Análise de glicocorticosteróides por CG-EM: uma nova abordagem de derivatização para o controle de dopagem no esporte. Química Nova, 25, 1096–1102.
   Google Scholar
• Pereira, H. M., Marques, M. A., Talhas, I. B., & Aquino Neto, F. R. (2004). Incidental clostebol contamination in athletes after sexual intercourse. Clinical Chemistry, 50, 456–457.
   PubMed Web of Science ®Google Scholar
• Pereira, H. M. G., Padilha, M. C., Bento, R. M. A., Cunha T. P., Lascas, N. A. G., & Aquino Neto, F. R. (2008). Analytical and logistical improvements in doping-control analysis at the 2007 Pan-American Games. Trends in Analytical Chemistry, 27, 648–656.
   Web of Science ®Google Scholar
• Pereira, H. M., Padilha, M. C., & Neto, F. R. (2009). Tetrahydrogestrinone analysis and designer steroids revisited. Bioanalysis, 1, 1475–1489.
   PubMed Web of Science ®Google Scholar
• Perrenoud, L., Saugy, M., & Saudan, C. (2009). Detection in urine of 4-methyl-2-hexaneamine, a doping agent. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 877, 3767–3770.
   PubMed Web of Science ®Google Scholar
• Pluim, B. (2008). A doping sinner is not always a cheat. British Journal of Sports Medicine, 42, 549–550.
   PubMed Web of Science ®Google Scholar
• Presidency of the Republic. (2010). Establish the Comprehensive Plan to Combat Crack and other Drugs, Creates its Manager Committee, and other Matters, Decree n. 7, 179, Brasília, Brazil.
   Google Scholar
• Rodrigues, J. L. (2011). Agência Mundial Antidoping recorre para ampliar suspensão do atacante Jóbson. Jornal O Globo, publicado em 04/01/2011 0h00 em: http://oglobo.globo.com/ esportes/agencia-mundial-antidoping-recorre-para-ampliar-sus pensao-do-atacante-jobson-2842897
   Google Scholar
• Rossi, S. S., Abate, M. G., Bragano, M. C., & Botrè, F. (2010). Use of stimulants and drugs of abuse in Sport: The Italian experience. Adicciones, 21, 239–242.
   Web of Science ®Google Scholar
• Ryan, D. H. (2000). Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity. Endocrine, 13, 193–199.
   PubMed Web of Science ®Google Scholar
• Sabino, C. (2002). Anabolizantes: drogas de Apolo. Nu & vestido. Dez antropólogos revelam a cultura do corpo carioca. Rio de Janeiro: Editora Record.
   Google Scholar
• Santos, A. M., Rocha, M. S. P. da, & Silva, M. F. da. (2011) Illicit use and abuse of anabolic-androgenic steroids among Brazilian bodybuilders. Substance Use & Misuse, 46, 742–748.
   PubMed Web of Science ®Google Scholar
• Sardela, V. F., Deventer, K., Pereira, H. M., de Aquino Neto F. R., & Van Eenoo, P. (2012) Development and validation of a ultra high performance liquid chromatography-tandem mass spectrometric method for the direct detection of formoterol in human urine. Journal of Pharmaceutical and Biomedical Analysis, 70, 471–475
   PubMed Web of Science ®Google Scholar
• Sardela, V. F., Motta, M. T., Padilha, M. C., Pereira, H. M., & Neto, F. R. (2009). Analysis of sibutramine metabolites as N-trifluoroacetamide and O-trimethylsilyl derivatives by gas chromatography-mass spectrometry in urine. Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences, 877, 3003–3011.
   PubMedGoogle Scholar
• Sardela, V. F., Sardela, P., Deventer, K., Araujo, A. L., Cavalcante, K. M., Padilha, M. C. & Neto, F. R. A. (2013). Identification of sympathomimetic alkylamine agents in urine using liquid chromatography-mass spectrometry and comparison of derivatization methods for confirmation analyses by gas chromatography-mass spectrometry. Journal of Chromatography A, 1298, 76–85.
   PubMed Web of Science ®Google Scholar
• Sardela, V. F., Sardela, P. D., Pereira, H. M., & Aquino Neto, F. R. (2011). Consequences of the formation of 3,4-dimethyl-5-phenyl-1,3-oxazolidine on the analysis of ephedrines in urine by gas chromatography and a new method for confirmation as N-trifluoroacetyl-O-t-butyldimethylsilyl ether derivatives. Journal of Chromatography A, 1218, 1266–1272.
   PubMed Web of Science ®Google Scholar
• Saur, A. M., & Pasian, S. R. (2008) Satisfaction with body image in adults of different body weights. Avaliação Psicológica, 7, 199–209.
   Google Scholar
• Silva Jr, A. I., Pereira, H. M., Casilli, A, Conceição, F. C., & Aquino Neto, F. R. (2009). Analytical challenges in doping control: Comprehensive two-dimensional gas chromatography with time of flight mass spectrometry, a promising option. Journal of Chromatography A, 1216, 2913–2922.
   PubMed Web of Science ®Google Scholar
• Silva, M., & Campesatto-Mella, E. A. (2008). Avaliação do uso de anorexígenos por acadêmicas de uma instituição de ensino superior em Maringá. Arquivos de Ciência da Saúde Unipar, 12, 43–50.
   Google Scholar
• Silveira, Filho, D., & César, A. C. (1991). Perfil de usuários de drogas: caracterização dos pacientes atendidos no ambulatório do PROAD/EPM em 1989. Revista de Saúde Pública, 13, 39–42.
   Google Scholar
• Stunkard, A. J. (1982). Anorectic agents lower a body weight set point. Life Sciences, 30, 2043–2055.
   PubMed Web of Science ®Google Scholar
• Thevis, M., Sigmund, G., Geyer, H., & Schänzer, W. (2010). Endocrinology and Metabolism Clinics of North America, 39, 89–105.
   PubMed Web of Science ®Google Scholar
• Thomas, A., Schänzer W., Delahaut, P., & Thevis, M. (2012). Immunoaffinity purification of peptide hormones prior to liquid chromatography-mass spectrometry in doping controls. Methods, 56, 230–235.
   PubMed Web of Science ®Google Scholar
• Tokish, J. M., Kocher, M. S., & Hawkins, R. J. (2004). Ergogenic aids: A review of basic science, performance, side effects, and status in sports. The American Journal of Sports Medicine, 32, 1543–1553.
   PubMed Web of Science ®Google Scholar
• Toyne, J. M. (1999). The transformation of coca to cocaine: An overview of traditional drug use and modern drug use, Totem: The University of Western Ontario Journal of Anthropology, 7, 21–31.
   Google Scholar
• United Nations, UNODC. (2010). United Nations Office on Drugs and Crime (UNODC), World Drug Report 2010. Retrieved December 23, 23, from United Nations. Web site: http://www.unodc.org/documents/wdr/WDR_2010/World_Drug_ Report_2010_lo-res.pdf
   Google Scholar
• United Nations, UNODC. (2011). World Drug Report. Annual Relatory 2007. New York, NY: United Nation Office on Drugs and Crime (UNODC).
   Google Scholar
• Van Eenoo, P., & Delbeke, F. T. (2010). β-adrenergic stimulation, doping in sports: Biochemical principles, effects and analysis. In: D. Thieme, P. Hemmerbach (Eds.), Handbook of Experimental Pharmacology (pp 195). Ney York: Springer Press.
   Google Scholar
• Van Eenoo, P., Delbeke, F. T., Roels, K., & De Backer, P. (2001). Simultaneous quantitation of ephedrines in urine by gas chromatography-nitrogen-phosphorus detection for doping control purposes. Journal of Chromatography B Biomedical Science Applications, 760, 255–261.
   PubMedGoogle Scholar
• Verroken, M. (2000). Drug use and abuse in sport. Best Practice & Research Clinical Endocrinology & Metabolism, 14, 1–23.
   PubMed Web of Science ®Google Scholar
• Voy, R. O., Deeter, K. D. (1991). Drugs, Sport and Politics (pp 227). Champaign, IL: Leisure Press
   Google Scholar
• WADA (2012a). International Standards for Laboratories. Retrieved December 23, 2012. WADA. Web site: http://www. wada-ama.org/Documents/World_Anti-Doping_Program/WA DP-IS-Laboratories/ISL/WADA_Int_Standard_Laboratories_ 2012_EN.pdf
   Google Scholar
• WADA (2012b). Laboratory-Statistics. Retrieved December 21, 2012, from World Anti-Doping Agency. Web site: http://www. wada-ama.org/en/Anti-Doping-Community/Anti-Doping-Labo ratories/Laboratory-Statistics/
   Google Scholar
• WADA (2012c). Why is there a discrepancy in the number of samples analyzed by the laboratories?. Retrieved December 23, 2012 from WADA. Web site: http://www.wada-ama.org/en/ Anti-Doping-Community/Anti-Doping-Laboratories/Laborat ory-Statistics/QA-on-2010-Laboratory-Statistics/
   Google Scholar
• WADA (2014). The 2014 Prohibited List. Retrieved 15 April, 2014, from WADA. Web site: http://www.wada-ama.org/Documents/ World_Anti-Doping_Program/WADP-Prohibited-list/2014/ WADA-prohibited-list-2014-EN.pdf
   Google Scholar
• Wagner, J. C. (1991). Enhancement of athletic performance with drugs. An overview. Sports Medicine, 12, 250–265.
   PubMed Web of Science ®Google Scholar